seagen-inc
Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion.

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal
IHSG
7.036,20
0.58%
-40,83
LQ45
1.009,04
0.44%
-4,47
USD/IDR
15.243
0,58
EMAS
942.000
1,07%